Site Networks & SMOs

U.S. clinical site network and clinical sciences platform focused on CNS and early-phase development, with dedicated psychedelic research expertise and integrated patient recruitment operations.

UK clinical research organization and site operator focused on complex CNS and psychedelic studies, with dedicated psychedelic testing suites and early-to-late phase delivery capabilities.

Physician-led New Zealand clinical research organization with early-phase specialization and multi-site operations; identified in partner disclosures as experienced in psychedelic studies.